The Evolving Role of Inflammatory Biomarkers in Risk Assessment After Stent Implantation
- 23 November 2010
- journal article
- review article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 56 (22), 1783-1793
- https://doi.org/10.1016/j.jacc.2010.06.045
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Relationship Between Baseline Inflammatory Markers, Antiplatelet Therapy, and Adverse Cardiac Events After Percutaneous Coronary InterventionCirculation: Cardiovascular Interventions, 2009
- Final 5-Year Results of the TAXUS II TrialCirculation, 2009
- Correlation of Intravascular Ultrasound Findings With Histopathological Analysis of Thrombus Aspirates in Patients With Very Late Drug-Eluting Stent ThrombosisCirculation, 2009
- Prognostic impact of preprocedural C reactive protein levels on 6-month angiographic and 1-year clinical outcomes after drug-eluting stent implantationHeart, 2007
- Effect of thiazolidinedione therapy on restenosis after coronary stent implantation: A meta-analysis of randomized controlled trialsAmerican Heart Journal, 2007
- Steroid-eluting stents in patients with acute coronary syndrome: the Dexamethasone Eluting Stent Italian REgistryHeart, 2007
- C-reactive protein gene polymorphisms and the incidence of post-angioplasty restenosisAtherosclerosis, 2004
- Adjunctive Pharmacotherapy before Percutaneous Coronary Intervention in Non-ST-Elevation Acute Coronary Syndromes: The Role of Modulating InflammationCirculation, 2003
- Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning studyAmerican Heart Journal, 2003
- Acute-Phase Proteins and Other Systemic Responses to InflammationThe New England Journal of Medicine, 1999